|
Co-Development Deals.
Through its association with many biotech companies over several
years, ERGOMED has gained considerable understanding of the specific
needs of the sector and awareness of where experience or resource
is most often lacking.
ERGOMED has shaped its clinical development and supporting organisation
to help to meet the specific needs of biotech. These include, for
example, provision of regulatory services, enhanced patient recruitment
using site management teams and study site co-ordinators, safety
database and drug safety monitoring, and special quality assurance
and audit services.
ERGOMED can offer very practical assistance in managing all aspects
of clinical development programmes from phases I and II through
subsequent corporate and regulatory milestones. For all these essential
tasks within clinical product development ERGOMED has build up
long time experienced staff but staying with a size which guarantees
personal relationship to its clients and partners.
How ERGOMED can benefit Biotech:
• Provision of services to meet specific needs such as drug safety monitoring,
regulatory services and advice, Quality Assurance and audit management, SOP writing,
data management.
• Creation of customised teams of experts
• Warranted patient recruitment timelines
• Opportunities for risk-sharing and co-development
|
